 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
7/13/23 Flagship Ventures Fund V, L.P. SC 13D/A 1:307K Evelo Biosciences, Inc. Donnelley … Solutions/FA
Flagship Pioneering Fund VII General Partner LLC³
Flagship Pioneering Fund VII, L.P.³
Flagship Pioneering, Inc.³
Flagship V Venturelabs RX Fund, L.P.³
Flagship Venturelabs IV LLC³
Flagship Venturelabs V LLC³
Flagship Venturelabs V Manager LLC³
Flagship Ventures Fund IV General Partner LLC³
Flagship Ventures Fund IV, L.P.³
Flagship Ventures Fund IV-RX, L.P.³
Flagship Ventures Fund V General Partner LLC³
Flagship Ventures Opportunities Fund I General Partner LLC³
Flagship Ventures Opportunities Fund I, L.P.³
Noubar B. Afeyan, Ph.D.³
Nutritional Health Disruptive Innovation Fund, L.P.³
Nutritional Health LTP Fund, L.P.³
Nutritional Health LTP General Partner LLC³
Nutritional Health Side Fund, L.P.³
7/7/22 Flagship VentureLabs IV, LLC SC 13D/A 1:223K Seres Therapeutics, Inc. Donnelley … Solutions/FA
Flagship Pioneering Fund VI General Partner LLC³
Flagship Pioneering Fund VI, L.P³
Flagship Pioneering Fund VII General Partner LLC³
Flagship Pioneering Fund VII, L.P.³
Flagship Pioneering, Inc.³
Flagship Ventures Fund IV General Partner LLC³
Flagship Ventures Fund IV, L.P³
Flagship Ventures Fund IV-RX, L.P.³
Noubar B. Afeyan, Ph.D³
Nutritional Health LTP Fund General Partner LLC³
Nutritional Health LTP Fund, L.P.³
6/1/22 Flagship Ventures Fund V, L.P. SC 13D/A 2:345K Evelo Biosciences, Inc. Donnelley … Solutions/FA
Flagship Pioneering Fund VII General Partner LLC³
Flagship Pioneering Fund VII, L.P.³
Flagship Pioneering, Inc.³
Flagship V Venturelabs RX Fund, L.P.³
Flagship Venturelabs IV LLC³
Flagship Venturelabs V LLC³
Flagship Venturelabs V Manager LLC³
Flagship Ventures Fund IV General Partner LLC³
Flagship Ventures Fund IV, L.P.³
Flagship Ventures Fund IV-RX, L.P.³
Flagship Ventures Fund V General Partner LLC³
Flagship Ventures Opportunities Fund I General Partner LLC³
Flagship Ventures Opportunities Fund I, L.P.³
Noubar B. Afeyan, Ph.D.³
Nutritional Health Disruptive Innovation Fund, L.P.³
Nutritional Health LTP Fund, L.P.³
Nutritional Health LTP General Partner LLC³
Nutritional Health Side Fund, L.P.³
| ____________ | | ¹ | Filing/Form Type: /A | | SC 13D | Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
